1.60
+15.11%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Universe Pharmaceuticals
Its shares trade under the ticker UPC. It has been listed since 23 March 2021. In the fiscal year to 30 September 2025, it reported revenue of $17.9m and a net loss of $3.7m. At that date it held total assets of $69.3m and shareholders' equity of $56.1m.
Universe Pharmaceuticals Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Ji'An, Jiangxi. The company went IPO on 2021-03-23. Universe Pharmaceuticals Inc is a holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, The Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments and cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. The firm mainly conducts its businesses within the China market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Mar 2021
- Employees
- 216
- Website
- dzrzy.com ↗
- Head office
- 265 JINGJIU AVENUE, JI'AN, JIANGXI, F4, 343100
- Incorporated in
- F4
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Gang LaiChairman of the Board, Chief Executive Officer
- Ms. Lin YangChief Financial Officer, Director
- Mr. Baochang LiuChief Operating Officer
- Mr. Jiawen PangIndependent Director
- Mr. H. David ShermanIndependent Director
- Mr. Ding ZhengIndependent Director
- Ms. Tina XiaoIR Contact Officer, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Universe Pharmaceuticals Inc employs 216 employees in Ji'an, Jiangxi for TCMD manufacturing and sales.
- The company's TCMD products include Guben Yanling Pill and Fengshitong Medicinal Liquor for chronic conditions.
- Universe Pharmaceuticals Inc focuses on elderly care with TCMPs and dietary supplements in China's Health Care sector.
Weaknesses
- Universe Pharmaceuticals Inc has only 176 full-time employees in Ji'an, Jiangxi for TCMD operations.
- The company relies on third-party manufacturers for biomedical drugs and medical instruments.
- Universe Pharmaceuticals Inc's business is limited to the China market without international expansion.
Opportunities
- Universe Pharmaceuticals Inc can expand TCMD product lines to include more cold and flu medications like Isatis Root Granule.
- The growing elderly population in China presents opportunities for TCMD chronic condition treatments.
- China's Health Care sector shows potential for increased demand for traditional Chinese medicine derivatives.
Threats
- Universe Pharmaceuticals Inc faces competition from other CN-based pharmaceutical companies in the Health Care sector.
- The company's reliance on third-party manufacturers may lead to supply chain disruptions.
- Regulatory changes in China's Pharmaceuticals industry could impact TCMD product approvals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.